Maternal Hyperoxygenation ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
211Hypoplastic left heart syndrome2

211. Hypoplastic left heart syndrome


Clinical trials : 22 Drugs : 29 - (DrugBank : 9) / Drug target genes : 5 - Drug target pathways : 14
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03136835
(ClinicalTrials.gov)
February 2, 201828/10/2015Maternal Hyperoxygenation in Congenital Heart DiseaseMaternal Hyperoxygenation in Congenital Heart DiseaseHypoplastic Left Heart SyndromeDrug: Maternal HyperoxygenationThe Hospital for Sick ChildrenNULLRecruiting18 YearsN/AFemale20Phase 1/Phase 2Canada
2NCT03147014
(ClinicalTrials.gov)
January 1, 20164/5/2017Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart DiseaseCardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart DiseaseHypoplastic Left Heart Syndrome;Aortic Coarctation;Atrial Septal AneurysmBiological: Maternal hyperoxygenationBeijing Anzhen HospitalNULLRecruitingN/AN/AFemale600N/AChina